Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
Authors
Keywords
SARS-CoV-2, COVID-19, hPSCs, cardiovascular cells, disease modeling, drug screening, myocardial injury, arrhythmias, cytokine storm
Journal
Stem Cell Reports
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-11
DOI
10.1016/j.stemcr.2020.11.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Laboratory abnormalities in patients with COVID-2019 infection
- (2020) Giuseppe Lippi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties
- (2020) Lettine van den Brink et al. Stem Cell Research
- Current status of potential therapeutic candidates for the COVID-19 crisis
- (2020) Jiancheng Zhang et al. BRAIN BEHAVIOR AND IMMUNITY
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
- (2020) Tomasz J Guzik et al. CARDIOVASCULAR RESEARCH
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
- (2020) Shi-Hui Sun et al. Cell Host & Microbe
- Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease
- (2020) Elisa Giacomelli et al. Cell Stem Cell
- Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
- (2020) Dan M. Roden et al. CIRCULATION
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
- (2020) Gregorio Tersalvi et al. JOURNAL OF CARDIAC FAILURE
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- Blinded, multi-centre evaluation of drug-induced changes in contractility using human induced pluripotent stem cell-derived cardiomyocytes
- (2020) Umber Saleem et al. TOXICOLOGICAL SCIENCES
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy
- (2020) Rosanna Asselta et al. Aging-US
- Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
- (2020) Yong-Jian Geng et al. CARDIOVASCULAR PATHOLOGY
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
- (2020) Liuliu Yang et al. Cell Stem Cell
- Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
- (2020) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
- (2020) Masataka Nishiga et al. Nature Reviews Cardiology
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- Cells of the adult human heart
- (2020) Monika Litviňuková et al. NATURE
- Neuropilin-1 is a host factor for SARS-CoV-2 infection
- (2020) James L. Daly et al. SCIENCE
- Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- (2020) Ludovico Cantuti-Castelvetri et al. SCIENCE
- Induced pluripotent stem cells in disease modelling and drug discovery
- (2019) R. Grant Rowe et al. NATURE REVIEWS GENETICS
- Differentiation and Functional Comparison of Monocytes and Macrophages from hiPSCs with Peripheral Blood Derivatives
- (2019) Xu Cao et al. Stem Cell Reports
- Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications
- (2019) Stephanie I. Protze et al. Cell Stem Cell
- Disease-Inspired Tissue Engineering: Investigation of Cardiovascular Pathologies
- (2019) LaTonya R. Simon et al. ACS Biomaterials-Science & Engineering
- Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects
- (2019) Mostafa Samak et al. Cells
- Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
- (2019) David T. Paik et al. PHARMACOLOGICAL REVIEWS
- International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
- (2018) Ksenia Blinova et al. Cell Reports
- From Pluripotent Stem Cells to T cells
- (2018) Amélie Montel-Hagen et al. EXPERIMENTAL HEMATOLOGY
- Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform
- (2016) Chris Denning et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Heart-on-a-chip based on stem cell biology
- (2016) Elzbieta Jastrzebska et al. BIOSENSORS & BIOELECTRONICS
- Complex Tissue and Disease Modeling using hiPSCs
- (2016) Robert Passier et al. Cell Stem Cell
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine
- (2016) Elena Matsa et al. PHYSIOLOGICAL REVIEWS
- Human Engineered Heart Tissue: Analysis of Contractile Force
- (2016) Ingra Mannhardt et al. Stem Cell Reports
- Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
- (2015) Vicente F. Corrales-Medina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Repolarization reserve, arrhythmia and new drug development
- (2013) Yang Li et al. Acta Pharmaceutica Sinica B
- Physiological aspects of cardiac tissue engineering
- (2012) Thomas Eschenhagen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum
- (2011) Cécile Crosnier et al. NATURE
- Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling Pathway
- (2010) I.-Y. Chen et al. JOURNAL OF VIROLOGY
- Elevated fibroblast growth factor-2 increases tumor necrosis factor-α induced endothelial cell death in high glucose
- (2008) Alisa Morss Clyne et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More